Dr. Eli Shalom
CEO & Co- Founder
An experienced radiopharmacist. Prior to founding Isotopia he was involved for eight years in the research and development and production of SPECT and PET isotopes in the National Nuclear Research Center at Nahal Soreq. With a Ph.D degree from the Hebrew University (Jerusalem) in the Synthesis of Novel Amine [18F] Fluorocyanoboranes & Amine [18F] Fluorocarboxyborane Esters, Dr. Shalom is regarded as one of the leading professionals in this sector in Israel. He is well known as a knowledgeable researcher with practical applications in product development of radio-isotopes including SPECT & PET tracers.
Dr. Shalom has a registered patent in this field as well as many publications in the professional literature.
Director of Business Development
Joined isotopia from the Foundation in 2007 as the company’s customer service and support. keren has taken on very quickly the sales and marketing division and managed the department for the last six years, during which she launched the unique diagnostic product Ga-68 PSMA and approve it for reimbursement by MOH.
Currently manages the business development department and a student at Tel Aviv University studying Health System Director. The first product launched under the Business Development Lu177-PSMA as a unique and innovative therapy for the treatment of prostate cancer.
Keren’s focus is to identify trends and opportunities in nuclear medicine, to bring new technologies and promote collaboration with global manufacturers.
Global Marketing and Sales Director
Rina Bar joined Isotopia in October 2020 as the global marketing and sales director.
She is bringing with her a rich experience and broad spectrum of achievements as sales and marketing senior manager within various global medical device and pharmaceutical companies.
Rina’s education in life science (M.SC, Bar Ilan university) and business management (MBA degree) is standing next to her during her entire professional career.
In the last 12 years of Rina’s career she focused her professional efforts in the dental medical device market, working as the VP of marketing of Alpha-Bio Tec and the marketing and sales director of Forumtec. Her contribution to both companies was in marketing and sales strategies and plans development as well as their successful execution.
In Isotopia, Rina is responsible for the development of new sales and marketing strategies, to reinforce Isotopia’s brand and to identify new business opportunities, and new markets to expand the company’s sales and revenue.
Eyal Gimshi, M.Sc
Head of therapy unit
Eyal Gimshi joined Isotopia from the company onset, initially as an accelerator operator on a part-time basis, while studying towards his bachelor degree in Nuclear Engineering. Subsequently Eyal became a full-timer and completed his master’s degree in Nuclear Engineering from Ben Gurion University, his thesis on a research project using the cyclotron in Isotopia.
In his role as Chief Operating Officer Eyal has successfully steered the corporate operation to a highly efficient and advanced radiopharmaceutical producer.
Eyal holds a MBA in technology management, is happily married and a father of 2 beautiful daughters.
Head of Sterile plant
With over 10 years practice managing complex operation units in global competitive environment, Tzachi joined Isotopia to lead the aseptic site. Tzachi holds a Bsc. in Industrial Engineering with MBA, and PMP Certified, and has proven track record in establishment of lean operational structures, processes and systems. He is Strong Change leader in key areas of Logistics, Manufacturing, Supply Chain, Finance, Engineering, Quality Assurance and Compliance.
Tzachi is happily married and father of 3 energetic sons.
Petach Tikva site manager
Amit is the chief financial officer at Isotopia and leads the company’s Accounting & finance. Amit has more than ten year’s experience in financial planning, accounting, budgeting and strategy and cash flow management. Prior to joining Isotopia, Amit was the CFO at Maya Tours and its subsidiaries. Earlier in her career, she held several leadership positions, including the CFO at The Commercial Company of the Israel Bar Association Ltd and the financial controller at Yedioth Ahronoth Magazines. Amit holds a B.A in Economics and Admonition and graduated from the Accounting Studies program at The College of Management Academic Studies. She is a certified CPA.
Dr. Haim Golan
Dr. Golan was the Director of Nuclear Medicine at Assaf Harofeh Medical Center, Israel. Currently he is the chief medical officer at “Isotopia molecular imaging”. He is one of Israel’s leading Nuclear Medicine physicians, having presented at numerous seminars, written scores of abstracts and publications.
Dr. Golan received his MD from Ben-Gurion University. He trained in Nuclear Medicine at Soroka Medical Center and has been practicing Nuclear Medicine since 1989.
Especially noteworthy is Dr. Golan’s strong scientific background. In addition to his MD Dr. Golan holds B.Sc and M.Sc degrees in Radiobiology from the Biology Department at Ben Gurion University.
Dr. Golan has done extensive research in the fields of nuclear brain imaging both in Israel and abroad as a Clinical Fellow in the department of medical Imaging, University of Toronto, Canada, in the division of Nuclear Medicine, Mount Sinai Hospital and in the division of Nuclear Medicine, Sick Children Hospital.
Dr. Golan harbors a special interest in brain SPECT and PET imaging, he utilizes his expertise in this area, as one of only a handful such experts throughout Israel who perform the cutting edge scans on a variety of patients including patients suffering from Parkinson’s disease.